Free Trial

NeuroBo Pharmaceuticals (NRBO) SEC Filings & 10K Form

NeuroBo Pharmaceuticals logo
$2.67
+0.10 (+3.89%)
(As of 11/1/2024 ET)

Recent NeuroBo Pharmaceuticals SEC Filings

DateFilerForm TypeView
10/07/2024
6:00 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
7:07 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
3:20 PM
DONG-A ST CO., LTD (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:10 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:01 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
7:00 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form PRE 14A
07/30/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2024
11:15 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form EFFECT
07/24/2024
4:11 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 424B3
07/18/2024
7:21 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/16/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
10:11 AM
DONG-A ST CO., LTD (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Form 4/A
06/26/2024
8:15 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
3:15 PM
DONG-A ST CO., LTD (Filed by)
NeuroBo Pharmaceuticals, Inc. (Subject)
NeuroBo Pharmaceuticals (Subject)
Form SC 13D/A
06/25/2024
3:16 PM
DONG-A ST CO., LTD (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
7:21 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 424B5
06/25/2024
7:00 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2024
5:01 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
6:24 PM
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Tursi James Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:24 PM
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
STRICKLAND D GORDON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:25 PM
Glickman Mark A (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:25 PM
KOVEN ANDREW I (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:26 PM
GROVES JASON L (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:26 PM
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Salsbury Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
8:00 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
7:05 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
7:41 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form DEF 14A
04/30/2024
7:42 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form ARS
04/30/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
11:15 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form EFFECT
04/17/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
3:30 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
7:01 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
8:20 PM
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Woodworth Marshall H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
7:52 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
True paradigm shift (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

02/01/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/18/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
7:45 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
8:00 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2023
8:03 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2023
8:20 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2023
4:12 PM
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Tursi James Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2023
7:20 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
3:39 PM
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Tursi James Patrick (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NRBO) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners